Prøve GULL - Gratis

Innovation and Enforcement in Food and Drug Safety

Business Standard

|

October 01, 2025

The Food and Drugs Administration (FDA) of Maharashtra has been steadily reinforcing its role as the state’s primary regulator for food products, medicines, medical devices, and cosmetics.

Its mandate extends beyond licensing and approvals to include strict enforcement, surveillance, and consumer education. The FDA's primary responsibilities revolve around safeguarding public health through licensing of food businesses and pharmaceutical firms, laboratory testing, inspections, and market monitoring. Its enforcement arm investigates violations, curbs adulteration, and penalises offenders, ensuring that both consumers and businesses comply with the highest standards of safety and quality.

Central to the FDA's work is the implementation of the Food Safety and Standards Act, 2006, along with the Drugs and Cosmetics Act, 1940. The department also enforces the Drug (Price Control) Order, 2013, to monitor affordability, and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, to curb misleading claims. These legislations form the backbone of Maharashtra’s regulatory framework.

FLERE HISTORIER FRA Business Standard

Business Standard

Business Standard

‘Investor awareness becomes more important than ever’

Ananth Narayan G describes his three-year tenure as whole-time member of the Securities and Exchange Board of India (Sebi) as a privilege that allowed him to make an impact on a larger canvas.

time to read

3 mins

November 01, 2025

Business Standard

Business Standard

New currency of hard power

If China is an exporting superpower, America is an importing one. Mr Trump has turned what would usually be a liability into an asset

time to read

5 mins

November 01, 2025

Business Standard

Business Standard

Apple's India revenue hits new high in Sep qtr

Apple set an all-time revenue record in India for the September quarter, driven by strong iPhone sales, as the American technology giant’s overall sales revenue reached $102.5 billion globally.

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

USFDA's new biosimilar norms to woo more players, fast-track mkt entry

The US Food and Drug Administration’s (USEDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic medicines — could significantly benefit Indian biotech companies.

time to read

2 mins

November 01, 2025

Business Standard

Business Standard

Apple revenue tops $100 bn for first time

iPhone price hike drives record quarter

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

Broking industry sees high growth on digital push

The Indian broking industry is passing through a lean patch after two years of rapid growth and expansion.

time to read

3 mins

November 01, 2025

Business Standard

Business Standard

Al-related stocks have more room to grow'

Artificial intelligence (AI)-related stocks have more room to grow, said Mark Matthews, managing director (MD) and head of research for Asia at Julius Baer during lunch on the sidelines of the Business Standard BFSI Insight Summit 2025 on Friday.

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

'Al unlikely to replace humans in fin services'

Artificial intelligence, or AI, has had an influence in the way we invest in stocks. While it helps you narrow the list of opportunities, it has not reached a point where it can replace wealth managers, points out Shankar Sharma, founder, GQuants, in a fireside chat with A K Bhattacharya. Edited excerpts:

time to read

4 mins

November 01, 2025

Business Standard

Business Standard

Vedanta net profit plunges 59% on exceptional losses

Mining major Vedanta’s consolidated net profit plunged 58.69 per cent year-on-year (Y-0-Y) to %1,798 crore inthe second quarter of 2025-26 (Q2FY26), dragged down by exceptional losses booked during the period under review. The company had reported anet exceptional gain of $1,160 crore in Q2FY25.

time to read

2 mins

November 01, 2025

Business Standard

Sebi chief stresses responsible tech use, stronger market resilience

The Securities and Exchange Board of India (Sebi) is promoting the responsible use of emerging technologies, such as artificial intelligence in financial markets, strengthening cybersecurity, and preparing entities for change, said Chairman Tuhin Kanta Pandey on Friday.

time to read

1 mins

November 01, 2025

Listen

Translate

Share

-
+

Change font size